A multicenter phase III prospective randomized trial of high-dose epirubicin in combination with cyclophosphamide (EC) versus docetaxel followed by EC in node-positive breast cancer. GOIM (Gruppo Oncologico Italia Meridionale) 9902 study

BACKGROUND: The Gruppo Oncologico Italia Meridionale 9902 trial compared four cycles of high-dose epirubicin plus cyclophosphamide (EC) with four cycles of docetaxel (Taxotere, D) followed by four cycles of EC as adjuvant treatment of node-positive breast cancer. PATIENTS AND METHODS: Patients were...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Vici, P., Brandi, M., Giotta, F., Foggi, P., Schittulli, F., Di Lauro, L., Gebbia, N., Massidda, B., Filippelli, G., Giannarelli, D., Di Benedetto, A., Mottolese, M., Colucci, G., Lopez, M.
Formato: Artigo
Lenguaje:Inglês
Publicado: Oxford University Press 2012
Materias:
Original Articles
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3362268/
https://ncbi.nlm.nih.gov/pubmed/21965475
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/annonc/mdr412
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares